$837 Million is the total value of Svennilson Peter's 7 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NGM | Buy | NGM Biopharmaceuticals Inc | $303,621,000 | +35.6% | 16,420,829 | +1.6% | 36.26% | -47.9% |
| CNST | Constellation Pharmceticls I | $283,117,000 | +629.3% | 6,009,702 | 0.0% | 33.81% | +180.2% | |
| RAPT | New | RAPT Therapeutics Inc | $187,118,000 | – | 6,777,151 | +100.0% | 22.34% | – |
| RCUS | Arcus Biosciences Inc | $35,763,000 | +11.0% | 3,540,850 | 0.0% | 4.27% | -57.4% | |
| GRTS | Gritstone Oncology Inc | $27,833,000 | +3.8% | 3,102,934 | 0.0% | 3.32% | -60.1% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- The Column Group II, LP #1
- The Column Group II GP, LP #2
- David Goeddel #3
- The Column Group, LP #4
- The Column Group GP, LP #5
- Ponoi Capital, LP #6
- Ponoi Management, LLC #7
- Tim Kutzkey #8
- Ponoi Capital II, LP #9
- Ponoi II Management, LLC #10
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CONSTELLATION PHARMCETICLS I | 8 | Q3 2020 | 33.8% |
| GRITSTONE ONCOLOGY INC | 8 | Q3 2020 | 42.2% |
| ARCUS BIOSCIENCES INC | 7 | Q2 2020 | 33.6% |
| NGM BIOPHARMACEUTICALS INC | 6 | Q3 2020 | 69.6% |
| RAPT Therapeutics Inc | 4 | Q3 2020 | 22.3% |
| Revolution Medicines Inc | 3 | Q3 2020 | 22.7% |
| Immune Design Corp. | 2 | Q1 2019 | 20.7% |
| ORIC Pharmaceuticals Inc. | 2 | Q3 2020 | 13.4% |
| Nurix Therapeutics Inc | 1 | Q3 2020 | 19.2% |
View Svennilson Peter's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-08 |
| 4 | 2023-11-17 |
| 4 | 2023-02-01 |
| 4 | 2023-01-25 |
| 4 | 2023-01-23 |
| 4 | 2023-01-17 |
| 4 | 2023-01-12 |
| 4 | 2022-12-14 |
| 4 | 2022-11-23 |
| 4 | 2022-11-07 |
View Svennilson Peter's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.